Guyatt G, Rennie D, Meade MO & Cook DJ. Users¡¯ Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice. 3rd ed., New York, USA: McGraw Hill Education & The JAMA Network. 2015.
DiCenzo R, ed. Clinical Pharmacist's Guide to Biostatistics and Literature Evaluation. 2nd ed., Lenexa, KS, USA: American College of Clinical Pharmacy. 2015.
Browner WS, Thomas B Newman TB, Cummings SR. Designing Clinical Research. 5th ed. Wolters Kluwer. 2022.
Malone PM, Witt BA, Malone MJ, Peterson DM. Drug Information: A Guide for Pharmacists, 7th ed. McGraw Hill. 2022.
Canadian Medical Association Journal (CMAJ) evidence based medicine (EBM) series
Wyer PC, et al. Tips for learning and teaching evidence-based medicine: Introduction to the series. CMAJ 2004;171:347-8.
Barratt A, et al. Tips for learners of evidence-based medicine: 1. Relative risk reduction, absolute risk reduction and number needed to treat. CMAJ 2004;171:353-8.
Montoria VM, et al. Tips for learners of evidence-based medicine: 2. Measures of precision (confidence intervals). CMAJ 2005;171:611-5.
2)Àü¹®¿µ¿ª °ü·Ã Âü°í¹®Çå
°¡)³ëÀÎ ¾à¹°¿ä¹ý ÃÑ·Ð
By the 2023 American Geriatrics Society Beers Criteria¢ç Update Expert Panel. American Geriatrics Society 2023 updated AGS Beers Criteria¢ç for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2023;71(7):2052-81.
O'Mahony D et al. STOPP/START criteria for potentially inappropriate prescribing in older people: version 3. Eur Geriatr Med 2023;14(4):625-32.
Moo-Young Kim et al. Development of a Consensus List of Potentially Inappropriate Medications for Korean Older Adults. Ann Geriatr Med Res 2018; 22(3):121-9.
Curtin D et al. Deprescribing in older people approaching end-of-life: development and validation of STOPPFrail version 2. Age Ageing 2020;50: 465-71.
³ª)³ëÀÎÁúȯ °¢·Ð
American Diabetes Association Professional Practice Committee; 13. Older Adults: Standards of Care in Diabetes-2025. Diabetes Care 1 January 2025; 48 (Supplement_1): S266-S282.
´ëÇÑ´ç´¢º´ÇÐȸ, 2025 ´ç´¢º´Áø·áÁöħ Á¦ 9ÆÇ
Global strategy for prevention, diagnosis, and management of COPD: 2025 Report
Kleindorfer DO, et al. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association. Stroke. 2021;52:e364-e467
Pink K, et al. Dementia: assessment, management and support: summary of updated NICE guidance. BMJ 2018; 361: k2438
Fazio S, Pace D, Maslow K, Zimmerman S, Kallmyer B. Alzheimer's Association Dementia Care Practice Recommendations. Gerontologist. 2018 Jan 18;58(suppl_1):S1-S9. doi: 10.1093/geront/gnx182.
Park HK, et al. 2022 Update of the Korean Clinical Practice Guidelines for Stroke: Antithrombotic Therapy for Patients with Acute Ischemic Stroke or Transient Ischemic Attack. Journal of Stroke 2022;24(1):166-175
Powers, et al. Guidelines for the Early Management of Patients with Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/ American Stroke Association. Stroke. 2019;50(12):e344-e418.
Reus VI, et al. The American Psychiatric Association Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia. Am J Psychiatry 2016; 173(5):543-6.
Pringsheim T, et al. Dopaminergic Therapy for Motor Symptoms in Early Parkinson Disease Practice Guideline Summary: A Report of the AAN Guideline Subcommittee. Neurology. 2021 Nov 16;97(20):942-957. doi: 10.1212/WNL.0000000000012868.
Tanner CM, Ostrem JL. Parkinson's Disease. N Engl J Med. 2024 Aug 1;391(5):442-452. doi: 10.1056/NEJMra2401857
Thaler A, Alcalay RN. Diagnosis and Medical Management of Parkinson Disease. Continuum (Minneap Minn). 2022 Oct 1;28(5):1281-1300. doi: 10.1212/CON.0000000000001152.
Armstrong MJ, et al. Diagnosis and Treatment of Parkinson Disease: A Review. JAMA. 2020;323(6):548-60.
Fox SH, et al. International Parkinson and Movement Disorder Society Evidence-Based Medicine Review: Update on Treatments for the Motor Symptoms of Parkinson's Disease. Mov Disord. 2018;33(8):1248-66.
Seppi K, et al. Update on Treatments for Nonmotor Symptoms of Parkinson's Disease-An Evidence-Based Medicine Review. Mov Disord. 2019;34(2):180-98.
Nemade D, et al. An Update on Medical and Surgical Treatments of Parkinson¡¯s Disease. Aging Dis. 2021; 12(4): 1021-35
Irwin GM. Urinary Incontinence. Prim Care Clin Office Pract 46 (2019) 233-42.
Parker WP, et al. Nonsurgical Treatment of Urinary Incontinence in Elderly Women. Clin Geriatr Med 2015; 31:471-85.
Àü¸³¼±ºñ´ëÁõ Áø·á±Ç°í¾È (2015)
Lerner LB, et al. Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART I-Initial Work-up and Medical Management. J Urol 2021;206(4):806-17
Sandhu JS, et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia (BPH): AUA Guideline amendment 2023. J Urol 2023;10.1097/JU.0000000000003698.
Kolasinski SL, et al. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. Arthritis Rheumatol 2020;72(2): 220-33.
Bruyere O, et al. An updated algorithm recommendation for the management of knee osteoarthritis from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Semin Arthritis Rheum. 2019;49(3):337-50.
Wang SM, et al. Korean Medication Algorithm Project for Depressive Disorder 2021 (IV): Female and Elderly; J Korean Neuropsychiatr Assoc. 2021;60(4):258-66
Kok RM. Management of Depression in Older Adults A Review. JAMA. 2017;317(20):2114-22.
½ÉºÎÀü Áø·áÁöħ 2022(´ëÇѽɺÎÀüÇÐȸ) 2022 KSHF Guideline for the Management of Heart Failure
Heidenreich PA, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145:e895-e1032. DOI: 10.1161/CIR.0000000000001063
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2021;42:3599-3726
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2023;44(37):3627-3639
2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease. A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2016;134(10):e123-155.
2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41(3):407-477
2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2023;82(9):833-955